Literature DB >> 3534864

The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease.

B Mettauer, J L Rouleau, P Daly.   

Abstract

The acute effects of captopril in three groups of patients with coronary artery disease were studied: 25 patients with congestive heart failure; 8 patients with hypertension; and 14 normotensive patients with angina, and systolic arterial pressure greater than 120 mmHg, but no evidence of heart failure. Systemic haemodynamics were assessed by balloon-tipped thermodilution catheter and coronary haemodynamics were assessed by thermodilution catheter in the coronary sinus. Despite significantly different baseline haemodynamic values, captopril decrease systolic arterial pressure without increasing heart rate in all three groups, thereby decreasing double-product, a major determinant of myocardial work. Coronary blood flow and myocardial oxygen consumption decreased similarly in all groups and decreased in parallel to double-product, while coronary vascular resistance and transmyocardial oxygen difference did not change except for a slight decrease in transmyocardial oxygen difference in those patients with congestive heart failure. Transmyocardial lactate extraction increased insignificantly. These findings suggest that captopril may improve metabolic balance in various types of patients with coronary artery disease and that it does this by decreasing myocardial oxygen demand.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534864

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  The renin-angiotensin-aldosterone system and cardiac ischaemia.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view.

Authors:  M H Alderman
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  ACE inhibitors for the treatment of myocardial ischemia?

Authors:  C Linder; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 4.  Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

Authors:  W J Remme
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 6.  The use of angiotensin-converting enzyme inhibitors in congestive heart failure.

Authors:  J L Rouleau; C Juneau; J de Champlain
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.